1-3 of 3
Ulrike Lorch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia

Suthesh Sivapalaratnam, Steve Austin, Ulrike Lorch, Matej Goricar, Gillian Lowe, Ashley Gosnell, Prafull S. Gandhi, Joseph Vogel, Jigar Amin, Andrew Law, Benny Sorensen, Catherine Rea
Journal: Blood
Blood (2024) 144 (Supplement 1): 3953.1.
https://doi.org/10.1182/blood-2024-203782
Published: 2024
Journal Articles

A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: Updated Results

Catherine Rea, Thomas York, Ulrike Lorch, Kate Khair, Luke Pembroke, Jigar Amin
Journal: Blood
Blood (2023) 142 (Supplement 1): 5439.
https://doi.org/10.1182/blood-2023-187558
Published: 2023
Journal Articles

A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia

Suthesh Sivapalaratnam, Steve Austin, Ulrike Lorch, Thomas York, Andrew Want, Ashley Gosnell, Prafull S. Gandhi, Henrik Østergaard, Erik Bjornson, Tara O'Meara, Benny Sorensen, Roger E.G. Schutgens, Catherine Rea
Journal: Blood
Blood (2023) 142 (Supplement 1): 1225.
https://doi.org/10.1182/blood-2023-187279
Published: 2023